TREAT California, a citizen-driven ballot initiative to fund research and access for psychedelic medicines to treat mental health, is withdrawing from the signature-gathering process.
While unprecedented positive results provide further proof of psilocybin’s anti-depressive effects, other studies investigate the long-term adverse effects of challenging trips. Meanwhile, the DEA wants to increase the manufacturing of certain psychedelics yet again as more psychedelic dispensaries are getting raided in Canada.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.